Figure 1.
Targeting PI3K isoforms with duvelisib, idelalisib, and copanlisib in the tumor and the microenvironment. TAM, tumor-associated macrophage.
Targeting PI3K isoforms with duvelisib, idelalisib, and copanlisib in the tumor and the microenvironment. TAM, tumor-associated macrophage.